×
Embecta Common Stock Net 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Embecta common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.
View More
Embecta Common Stock Net 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Embecta common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.1B
CVS Health (CVS)
$76.8B
Elevance Health (ELV)
$65.1B
Cencora (COR)
$56.3B
DiDi Global (DIDIY)
$25.7B
Labcorp Holdings (LH)
$22.2B
Natera (NTRA)
$19B
BioMerieux (BMXMF)
$17.7B
EUROFINS SCIENT (ERFSF)
$15.9B
ICON (ICLR)
$15.1B
CochLear (CHEOY)
$13.4B
Solventum (SOLV)
$12.9B
Medpace Holdings (MEDP)
$12.6B
Revvity (RVTY)
$12.2B
Viatris (VTRS)
$11B
Avantor (AVTR)
$9.7B
Sonic Healthcare (SKHHY)
$9.1B
Charles River Laboratories (CRL)
$8.7B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$7.5B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.5B
Surgery Partners (SGRY)
$2.7B
Organon (OGN)
$2.7B
Concentras Parent (CON)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B